ART4 and influenza: Following the successful use of S-Lux with influenza pseudotypes, we tested if glycoproteins from other infectious diseases could also be used to pseudotype S-Lux generating a reagent to facilitate the evaluation of anti-viral therapies targeted at the cognate glycoprotein and/or glycoprotein/receptor complex.